Related references
Note: Only part of the references are listed.NSAIDs and cardiovascular disease: time to say no to diclofenac
Patompong Ungprasert
INTERNAL AND EMERGENCY MEDICINE (2016)
The Use of Antiepileptics in Migraine Prophylaxis
Francesca Bagnato et al.
HEADACHE (2016)
Impact of migraine on fibromyalgia symptoms
Maria Adele Giamberardino et al.
JOURNAL OF HEADACHE AND PAIN (2016)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple Assays
Frances Neal et al.
JOURNAL OF BIOMOLECULAR SCREENING (2016)
Calcitonin Gene-Related Peptide (CGRP): A New Target for Migraine
Andrew F. Russo
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 55 (2015)
Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier
Sajedeh Eftekhari et al.
BRAIN RESEARCH (2015)
Therapeutic antibodies against CGRP or its receptor
Marcelo E. Bigal et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
CGRP receptor antagonists and antibodies against CGRP and its receptor in migraine treatment
Lars Edvinsson
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Targeting CGRP: A New Era for Migraine Treatment
Stephanie Wrobel Goldberg et al.
CNS DRUGS (2015)
Calcitonin gene-related peptide and migraine
Nazia Karsan et al.
CURRENT OPINION IN NEUROLOGY (2015)
TEV-48125: a Review of a Monoclonal CGRP Antibody in Development for the Preventive Treatment of Migraine
Sarah Walter et al.
CURRENT PAIN AND HEADACHE REPORTS (2015)
Update on Medication-Overuse Headache and Its Treatment
Maria Adele Giamberardino et al.
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2015)
Review of dose-response curves for acute antimigraine drugs: triptans, 5-HT1F agonists and CGRP antagonists
Anders Hougaard et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Therapeutic Monoclonal Antibodies: What Headache Specialists Need to Know
Stephen Silberstein et al.
HEADACHE (2015)
The Journey to Establish CGRP as a Migraine Target: A Retrospective View
Lars Edvinsson
HEADACHE (2015)
Fathoming the kynurenine pathway in migraine: why understanding the enzymatic cascades is still critically important
Martina Curto et al.
INTERNAL AND EMERGENCY MEDICINE (2015)
Headache disorders are third cause of disability worldwide
Timothy J. Steiner et al.
JOURNAL OF HEADACHE AND PAIN (2015)
New therapeutic approaches for the prevention and treatment of migraine
Hans-Christoph Diener et al.
LANCET NEUROLOGY (2015)
CGRP antibodies: the Holy Grail for migraine prevention?
Julio Pascual
LANCET NEUROLOGY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of chronic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Site of effect of LY2951742 for migraine prophylaxis
Peer Tfelt-Hansen
LANCET NEUROLOGY (2015)
Safety, tolerability, and efficacy of TEV-48125 for preventive treatment of high-frequency episodic migraine: a multicentre, randomised, double-blind, placebo-controlled, phase 2b study
Marcelo E. Bigal et al.
LANCET NEUROLOGY (2015)
Emerging treatments for the primary headache disorders
Nathaniel M. Schuster et al.
NEUROLOGICAL SCIENCES (2015)
The therapeutic armamentarium in migraine is quite elderly
Paolo Martelletti
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2015)
Emerging drugs for migraine treatment
Maria Adele Giamberardino et al.
EXPERT OPINION ON EMERGING DRUGS (2015)
The therapeutic potential of novel anti-migraine acute therapies
Donata Sabato et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2015)
Correlation between Migraine Severity and Cholesterol Levels
Claudio Tana et al.
PAIN PRACTICE (2015)
Translational Pharmacodynamics of Calcitonin Gene-Related Peptide Monoclonal Antibody LY2951742 in a Capsaicin-Induced Dermal Blood Flow Model
Steve Vermeersch et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2015)
Safety and tolerability of LBR-101, a humanized monoclonal antibody that blocks the binding of CGRP to its receptor: Results of the Phase 1 program
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Cardiovascular and hemodynamic parameters in women following prolonged CGRP inhibition using LBR-101, a monoclonal antibody against CGRP
Marcelo E. Bigal et al.
CEPHALALGIA (2014)
Monoclonal Antibodies for Migraine: Preventing Calcitonin Gene-Related Peptide Activity
Marcelo E. Bigal et al.
CNS DRUGS (2014)
Pain thresholds in women with chronic pelvic pain
Maria A. Giamberardino et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2014)
Safety and efficacy of LY2951742, a monoclonal antibody to calcitonin gene-related peptide, for the prevention of migraine: a phase 2, randomised, double-blind, placebo-controlled study
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Safety and efficacy of ALD403, an antibody to calcitonin gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial
David W. Dodick et al.
LANCET NEUROLOGY (2014)
Evaluation of cardiovascular parameters in cynomolgus monkeys following IV administration of LBR-101, a monoclonal antibody against calcitonin gene-related peptide
Sarah Walter et al.
MABS (2014)
CALCITONIN GENE-RELATED PEPTIDE: PHYSIOLOGY AND PATHOPHYSIOLOGY
F. A. Russell et al.
PHYSIOLOGICAL REVIEWS (2014)
CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors?
C. S. Walker et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
ICHD-3 beta is published. Use it immediately
Jes Olesen
CEPHALALGIA (2013)
Emerging Target-Based Paradigms to Prevent and Treat Migraine
S. D. Silberstein
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
CGRP Receptor Antagonism and Migraine Therapy
Lars Edvinsson et al.
CURRENT PROTEIN & PEPTIDE SCIENCE (2013)
Calcitonin Gene-Related Peptide (CGRP) and Migraine Current Understanding and State of Development
Marcelo E. Bigal et al.
HEADACHE (2013)
New insights into the cardiovascular risk of migraine and the role of white matter hyperintensities: is gold all that glitters?
Claudio Tana et al.
JOURNAL OF HEADACHE AND PAIN (2013)
Differentiation of Nerve Fibers Storing CGRP and CGRP Receptors in the Peripheral Trigeminovascular System
Sajedeh Eftekhari et al.
JOURNAL OF PAIN (2013)
Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine
Eva Cernuda-Morollon et al.
NEUROLOGY (2013)
CGRP receptor antagonists: an expanding drug class for acute migraine?
Andrea Negro et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
A case of typical headache with an atypical diagnosis
Alessio Pieroni et al.
INTERNAL AND EMERGENCY MEDICINE (2012)
Evidence for a Vascular Factor in Migraine
Mohammad S. Asghar et al.
ANNALS OF NEUROLOGY (2011)
Myofascial pain syndromes and their evaluation
Maria Adele Giamberardino et al.
BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY (2011)
Effects of Treatment of Myofascial Trigger Points on the Pain of Fibromyalgia
Maria Adele Giamberardino et al.
CURRENT PAIN AND HEADACHE REPORTS (2011)
Effects of treatment of peripheral pain generators in fibromyalgia patients
Giannapia Affaitati et al.
EUROPEAN JOURNAL OF PAIN (2011)
Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation
Ann C. Raddant et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2011)
Rehabilitating chronic migraine complicated by medication overuse headaches: how can we prevent migraine relapse?
Ivano Farinelli et al.
INTERNAL AND EMERGENCY MEDICINE (2011)
A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine
Marco Bartolini et al.
JOURNAL OF HEADACHE AND PAIN (2011)
Diencephalic and brainstem mechanisms in migraine
Simon Akerman et al.
NATURE REVIEWS NEUROSCIENCE (2011)
Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura
Jakob Moller Hansen et al.
CEPHALALGIA (2010)
Epidemiological classification and social impact of chronic headache
Gian Camillo Manzoni et al.
INTERNAL AND EMERGENCY MEDICINE (2010)
Chronic headaches and medication overuse
Pierangelo Geppetti et al.
INTERNAL AND EMERGENCY MEDICINE (2010)
Chronic migraine: comorbidities, risk factors, and rehabilitation
Andrea Negro et al.
INTERNAL AND EMERGENCY MEDICINE (2010)
Visceral Referred Pain
Maria Adele Giamberardino et al.
JOURNAL OF MUSCULOSKELETAL PAIN (2010)
Triptan Therapy in Migraine
Elizabeth Loder
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Viscero-visceral hyperalgesia: Characterization in different clinical models
Maria Adele Giamberardino et al.
PAIN (2010)
The vascular theory of migrainea great story wrecked by the facts
Peter J. Goadsby
BRAIN (2009)
A Randomized, Controlled Study Comparing a Lidocaine Patch, a Placebo Patch, and Anesthetic Injection for Treatment of Trigger Points in Patients With Myofascial Pain Syndrome: Evaluation of Pain and Somatic Pain Thresholds
Giannapia Affaitati et al.
CLINICAL THERAPEUTICS (2009)
Role of Calcitonin Gene-Related Peptide in Light-Aversive Behavior: Implications for Migraine
Ana Recober et al.
JOURNAL OF NEUROSCIENCE (2009)
Migraine: where and how does the pain originate?
Karl Messlinger
EXPERIMENTAL BRAIN RESEARCH (2009)
CGRP function-blocking antibodies inhibit neurogenic vasodilatation without affecting heart rate or arterial blood pressure in the rat
J. Zeller et al.
BRITISH JOURNAL OF PHARMACOLOGY (2008)
Involvement of calcitonin gene-related peptide in migraine: regional cerebral blood flow and blood flow velocity in migraine patients
L. H. Lassen et al.
JOURNAL OF HEADACHE AND PAIN (2008)
Contribution of Myofascial trigger points to migraine symptoms
Maria Adele Glamberardino et al.
JOURNAL OF PAIN (2007)
Calcitonin receptor-like and receptor activity modifying protein 1 in the rat dorsal horn localization in glutamatergic presynaptic terminal containing opioids and adrenergic α2c receptor
J. C. G. Marvizon et al.
NEUROSCIENCE (2007)
Recent advances in understanding migraine mechanisms, molecules and therapeutics
Peter J. Goadsby
TRENDS IN MOLECULAR MEDICINE (2007)
Calcitonin gene-related peptide (CGRP) and migraine
PL Durham
HEADACHE (2006)
BIBN4096BS antagonizes human α-calcitonin gene related peptide-induced headache and extracerebral artery dilatation
KA Petersen et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Sumatriptan causes parallel decrease in plasma calcitonin gene-related peptide (CGRP) concentration and migraine headache during nitroglycerin induced migraine attack
G Juhasz et al.
CEPHALALGIA (2005)
Migraine pathophysiology and its clinical implications
SD Silberstein
CEPHALALGIA (2004)
CGRP may play a causative role in migraine
LH Lassen et al.
CEPHALALGIA (2002)
Nitric oxide metabolites, prostaglandins and trigeminal vasoactive peptides in internal jugular vein blood during spontaneous migraine attacks
P Sarchielli et al.
CEPHALALGIA (2000)
Neurokinin-1 receptor agonists are involved in mediating neutrophil accumulation in the inflamed, but not normal, cutaneous microvasculature:: An in vivo study using neurokinin-1 receptor knockout mice
T Cao et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
